Let’s Work Together


Purpose of this Study

The study will be assessing the safety, tolerability and Pharmacokinetics of MH004 Topical Cream in Healthy Adult Volunteers and Investigate its Efficacy and Safety Profile in Participants with Mild to Moderate Atopic Dermatitis (Randomized, placebo-controlled 28-day repeated dosing)

Inclusion criteria

To take part in this study, participants need to be:

  • 18-70 years of age
  • Lives in Victoria
  • Experiencing mild to moderate eczema for at least 3 months
  • Not pregnant

Location of Study

Contact details

Why do I want to participate?

To identify the efficacy of the topical cream to better the life quality of adults who have mild to moderate Atopic Dermatitis.